Vivo Capital’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,704,568
Closed -$26.9M 50
2023
Q4
$26.9M Hold
1,704,568
2.2% 11
2023
Q3
$13.2M Hold
1,704,568
1.45% 18
2023
Q2
$16.9M Buy
+1,704,568
New +$13.6M 1.17% 13

Vivo Capital's ICVX Position: Q1 2024 in Review

Vivo Capital sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,704,568 shares — an estimated $26.9M sold.

Vivo Capital first reported a position in ICVX in Q2 2023 and held it in 3 quarters. The position peaked at $26.9M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Vivo Capital reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vivo Capital sold 1,704,568 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $26.9M.
  • Vivo Capital first reported a position in Icosavax, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Vivo Capital's Icosavax, Inc. Common Stock position peaked at $26.9M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Vivo Capital's 13F filing for Q1 2024, filed 22 Apr 2024.